Commercially available assays for multiplex detection of alpha human papillomaviruses (Q37800921)

23 August 2017

title

Commercially available assays for multiplex detection of alpha human papillomaviruses (English)

1 reference

23 August 2017

main subject

diagnostic reagent kit

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20954880

4 August 2024

author name string

Mario Poljak

1

1 reference

23 August 2017

Boštjan J. Kocjan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20954880

4 August 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20954880

4 August 2024

publication date

1 October 2010

1 reference

full work available at URL

23 August 2017

https://www.tandfonline.com/doi/pdf/10.1586/eri.10.104?needAccess=true

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20954880

http://www.future-drugs.com/doi/abs/10.1586/eri.10.104

4 August 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20954880

http://www.tandfonline.com/doi/pdf/10.1586/eri.10.104

4 August 2024

1 reference

Expert Review of Anti-infective Therapy

4 August 2024

published in

1 reference

23 August 2017

volume

8

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1139-1162

1 reference

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus and head and neck cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Systematic review of human papillomavirus prevalence in invasive penile cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Impact of improved classification on the association of human papillomavirus with cervical precancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Molecular diagnosis of human papillomavirus (HPV) infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Detection and typing of human papillomavirus nucleic acids in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

21 January 2018

HPV detection methods

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Methods for HPV detection in exfoliated cell and tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Validation of high-risk HPV tests for primary cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

How to evaluate emerging technologies in cervical cancer screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus genotype specificity of hybrid capture 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Special commentary: patient safety and the next generation of HPV DNA tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Population-based study of screening test performance indices of three human papillomavirus DNA tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

A study of Amplicor human papillomavirus DNA detection in the atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of molecular assays for detection and typing of human papillomavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

New technologies in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Principles and analytical performance of Abbott RealTime High Risk HPV test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Evaluation of the clinical performance of the Abbott RealTime High-Risk HPV for carcinogenic HPV detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Testing of a new probe 16/18/45 Hybrid Capture (Digene) in women with high risk HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of two PCR-based human papillomavirus genotyping methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of INNO-LiPA HPV Genotyping v2 with PCR product subcloning and sequencing for identification of genital human papillomavirus genotypes in African women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Digene HPV Genotyping RH Test RUO: comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Universal ProbeLibrary based real-time PCR assay for detection and confirmation of human papillomavirus genotype 52 infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus genotyping by a polymerase chain reaction-based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Quality assurance of genotyping array for detection and typing of human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus genotype in cervical cancer: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Incidence and outcome of acquisition of human papillomavirus infection in women with normal cytology--a population-based cohort study from Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Evaluation of an array-based method for human papillomavirus detection and genotyping in comparison with conventional methods used in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Characteristics of HPV prevalence among women in Liaoning province, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus genotyping using an automated film-based chip array

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Peptide nucleic acid-based array for detecting and genotyping human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Bead-based multiplex genotyping of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Polymerase chain reaction-based fluorescent Luminex assay to detect the presence of human papillomavirus types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Analytical characterization of the APTIMA HPV Assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Multiplex chemiluminescence microscope imaging of P16(INK4A) and HPV DNA as biomarker of cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

The role of human papillomavirus testing in cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus testing for primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Primary and secondary prevention of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

International agreement to join forces in synthesizing evidence on new methods for cervical cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

HPV screening for cervical cancer in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Evaluation of the performance of the novel PapilloCheck® HPV genotyping test by comparison with two other genotyping systems and the HC2 test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.104

Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors

21 January 2018

8

1 reference

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings

4 August 2024

20

1 reference

Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail

4 August 2024

30

1 reference

The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform

4 August 2024

39

1 reference

Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study

4 August 2024

40

1 reference

A comparison of two methods to determine the presence of high-risk HPV cervical infections

4 August 2024

45

1 reference

Comparison of methods trial for high-risk HPV

4 August 2024

46

1 reference

Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear

4 August 2024

57

1 reference

Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear

4 August 2024

60

1 reference

High-risk HPV detection and concurrent HPV 16 and 18 typing with Abbott RealTime High Risk HPV test

4 August 2024

69

1 reference

Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology

4 August 2024

70

1 reference

Comparison between the Abbott RealTime High Risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens

4 August 2024

71

1 reference

Detection of human papillomavirus genotypes 16/18/45 by hybrid capture hybridisation genotyping probe in clinical specimens: the first report

4 August 2024

77

1 reference

Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system

4 August 2024

94

1 reference

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay

4 August 2024

101

1 reference

A type-specific study of human papillomavirus prevalence in cervicovaginal samples in three different Spanish regions

4 August 2024

112

1 reference

A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP

4 August 2024

126

1 reference

High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology

4 August 2024

128

1 reference

Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma

4 August 2024

130

1 reference

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear

4 August 2024

137

1 reference

Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets

4 August 2024

142

1 reference

Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA.

4 August 2024

157

1 reference

4 August 2024

158

Gök

2010

1 reference

4 August 2024

Identifiers

DOI

10.1586/ERI.10.104

1 reference

23 August 2017

1 reference